Pharma Services Network, Inc. (www.PharmaServicesNet.com) announced today that it has signed a sales, marketing, and business development services contract with BioKinetic Europe, a leading clinical research organization (CRO) that specializes in conducting Phase 1 clinical trials in the United Kingdom (UK). Pharma Services Network will promote BioKinetic’s specialized clinical research capabilities to the growing North American Life Science industry.
“BioKinetic provides First in Man (FIM), QTc, and other Phase 1 clinical trials in the UK for sponsors who are seeking rapid study startup, a familiar, English-speaking environment, and expertise in Women’s Health, Pain Management, Diabetes, and Oncology. The UK is a great place for Phase 1 clinical research because of its 14-day regulatory approval cycle for studies,” says Moira Burke, Managing Director of BioKinetic Europe.
“Our team of experienced Life Science physicians and clinicians has conducted clinical research for many of the top American pharmaceutical companies. Now, with a representative office and Pharma Services Network’s organizational support, we hope to expand and improve our standing in the US marketplace.”
Pharma Services Network CEO Jim Worrell noted, “BioKinetic Europe is a world-class experienced CRO, and because of their location, can get regulatory approval for a study in just 14 days. This speed is important to sponsors - now more than ever. In today’s economy, compressing regulatory and development timelines is often key to keeping investors engaged.”
In addition to ICH GCP compliance, BioKinetic Europe operates within the UK (MHRA) and EU (EMEA) regulatory frameworks. The company has successfully completed both MHRA GCP and GMP inspections and has been awarded Supplementary Accreditation status in April 2009. BioKinetic also holds a current Manufacturing Authorization for IMP, which includes vaccines.
BioKinetic is the latest addition to the Pharma Services Network portfolio of world-class Contract Research Organizations (CROs) and other service providers to the Life Science industry.
Further information on BioKinetic’s FIM and other Phase 1 clinical research capabilities can be found online at: www.PharmaServicesNet.com/BioKinetic
About Pharma Services Network
From headquarters in Charlotte, NC, Pharma Services Network matches US study sponsors with the best CROs from around the world. The company’s promise is “The Right CRO…Right Now”. CROs that are represented by Pharma Services Network include leaders in Europe, India, Brazil, Africa and Russia. Online, see www.PharmaServicesNet.com. Global CROs looking for market support in the USA should apply through the company’s AmeriStart division at www.AmeriStart.com. For more information on Pharma Services and AmeriStart, contact David Worrell (dworrell@ameristart.com) or +1-803-746-4069.
About BioKinetic
BioKinetic, established in 1996, is a woman-owned Contract Research Organization offering regulatory and clinical trial services for Pharmaceutical and Biotech sponsors from headquarters in Northern Ireland, UK.
Contacts:
Pharma Services Network
Jonathan Mark,
803-746-4073
jmark@PharmaServicesNet.com